M & L Capital Management Ltd Has $9.65 Million Position in Intuitive Surgical, Inc. $ISRG

M & L Capital Management Ltd grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 17,750 shares of the medical equipment provider’s stock after buying an additional 50 shares during the period. Intuitive Surgical makes up 2.2% of M & L Capital Management Ltd’s investment portfolio, making the stock its 11th biggest position. M & L Capital Management Ltd’s holdings in Intuitive Surgical were worth $9,646,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Abner Herrman & Brock LLC increased its stake in shares of Intuitive Surgical by 152.1% in the second quarter. Abner Herrman & Brock LLC now owns 31,490 shares of the medical equipment provider’s stock valued at $17,112,000 after buying an additional 19,000 shares during the period. Thurston Springer Miller Herd & Titak Inc. increased its stake in shares of Intuitive Surgical by 22.6% in the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 2,810 shares of the medical equipment provider’s stock valued at $1,527,000 after buying an additional 518 shares during the period. Arvest Investments Inc. acquired a new stake in shares of Intuitive Surgical in the second quarter valued at about $297,000. TrueWealth Advisors LLC increased its stake in shares of Intuitive Surgical by 5.5% in the second quarter. TrueWealth Advisors LLC now owns 1,138 shares of the medical equipment provider’s stock valued at $618,000 after buying an additional 59 shares during the period. Finally, Norway Savings Bank increased its stake in shares of Intuitive Surgical by 53.4% in the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after buying an additional 910 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on ISRG. Truist Financial increased their price target on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, July 26th. BTIG Research upped their target price on Intuitive Surgical from $566.00 to $571.00 and gave the company a “buy” rating in a research report on Wednesday, July 23rd. Finally, Wells Fargo & Company upped their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research report on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $595.95.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $449.68 on Friday. The business’s 50 day simple moving average is $485.67 and its two-hundred day simple moving average is $508.21. The firm has a market cap of $161.20 billion, a P/E ratio of 62.72, a PEG ratio of 4.78 and a beta of 1.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company’s quarterly revenue was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.78 earnings per share. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of the stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director owned 1,074 shares in the company, valued at approximately $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,224 shares of company stock worth $21,716,492. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.